Weekly Insulin Jab Could Replace Daily Injections for Type 2 Diabetes Patients

A new weekly insulin jab could revolutionize the way people with type 2 diabetes manage their condition, potentially replacing daily injections for hundreds of thousands of individuals.

The treatment, which has been approved by the National Institute for Health and Care Excellence (Nice), works as well as daily insulin jabs but only needs to be injected once a week.

This shift from daily injections to a weekly jab is expected to benefit those who need help with their injections, including frailer people, those with sight loss, limited hand movement, and learning disabilities.

According to Diabetes UK, around 1 in 4 people with type 2 diabetes takes insulin, and this new treatment could make a significant difference in their lives.

Douglas Twenefour, head of clinical at Diabetes UK, emphasized the importance of supporting individuals who could benefit from this treatment, ensuring they are informed and able to make decisions about their care.

Helen Knight, director of medicines evaluation at Nice, highlighted the potential of this treatment to improve the day-to-day lives of people with type 2 diabetes, particularly those who rely on carers or healthcare professionals for assistance.

However, before this treatment can be made available on the NHS, it needs to be licensed by the Medicines and Healthcare products Regulatory Agency (MHRA).

Health officials are waiting on the MHRA's ruling to determine whether the treatment can be rolled out on the NHS.

The approval process for this treatment is complex, with different countries in the UK having their own processes for reviewing and implementing new medications.

The NHS in England, Wales, and Scotland will likely follow Nice's guidance, but the process in Northern Ireland is managed by the Department of Health.

### Potential Benefits of the New Treatment

The new weekly insulin jab has the potential to improve the lives of people with type 2 diabetes, particularly those who struggle with daily injections.

By reducing the number of injections needed each year by 86%, this treatment could make a significant difference in the lives of hundreds of thousands of individuals.

The benefits of this treatment are not limited to those who need help with their injections; it could also improve the quality of life for people with type 2 diabetes who struggle to stick to their treatment regime.

### Next Steps for the New Treatment

Before the new treatment can be made available on the NHS, it needs to be licensed by the MHRA.

Health officials are waiting on the MHRA's ruling to determine whether the treatment can be rolled out on the NHS.

Once licensed, the treatment will be available to those who could benefit from it, and healthcare teams will be able to support individuals in making informed decisions about their care.

The approval process for this treatment is complex, but with the potential benefits it offers, it is an exciting development for people with type 2 diabetes.

### Comparison of Daily and Weekly Insulin Jabs

| | Daily Insulin Jabs | Weekly Insulin Jabs | | --- | --- | --- | | Frequency of injections | Daily | Weekly | | Number of injections per year | 365 | 52 (86% reduction) | | Potential benefits | Improved quality of life for some individuals | Reduced number of injections, improved flexibility for those who need help with injections |